4//SEC Filing
Klapstein Julie D 4
Accession 0000896262-25-000087
CIK 0000896262other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:03 PM ET
Size
6.2 KB
Accession
0000896262-25-000087
Insider Transaction Report
Form 4
AMEDISYS INCAMED
Klapstein Julie D
Director
Transactions
- Disposition to Issuer
Common Stock
2025-08-14−16,031→ 0 total
Footnotes (2)
- [F1]On August 14, 2025, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Amedisys, Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of June 26, 2023 (as modified by the waiver, dated December 26, 2024, the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Aurora Holdings Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (other than certain excluded shares) automatically converted into the right to receive $101 per share in cash (the "Per Share Merger Consideration"), without interest and less any applicable withholding tax.
- [F2]Includes 1,690 time-based Restricted Stock Units ("RSUs") of the Issuer that were outstanding at the Effective Time that were cancelled and converted into the right to receive the Per Share Merger Consideration for each such outstanding RSU as of the Effective Time.
Documents
Issuer
AMEDISYS INC
CIK 0000896262
Entity typeother
Related Parties
1- filerCIK 0001518668
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:03 PM ET
- Size
- 6.2 KB